Apimeds Pharmaceuticals US, Inc. (APUS)

Finanzdaten der Apimeds Pharmaceuticals US, Inc.-Aktie (APUS)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	48.47%6.28	12.19	7.04	1.84	2.66
Research and Development	6.50%0.96	0.90	0.36	0.62	0.65
Operating Income/Loss	48.47%-6.28	-12.19	-7.04	-1.84	-2.66
Nonoperating Income/Loss	39.26%-13.89	-22.87	5.88	0.06	0.00
	42.46%-20.17	-35.06	-1.16	-1.78	-2.66
Attributable To Parent	42.46%-20.17	-35.06	-1.16	-1.78	-2.66
Basic Average Shares	88.96%1.71	15.51	-	12.58	10.37
Diluted Average Shares	88.96%1.71	15.51	-	12.58	10.37
Basic Earnings Per Share	420.80%-11.77	-2.26	-	-0.14	-0.26
Diluted Earnings Per Share	420.80%-11.77	-2.26	-	-0.14	-0.26